The Office of Administrative Law informed the DWC that seven areas of the proposed update required additional clarification or public notice.
The Office of Administrative Law informed the DWC that seven areas of the proposed update required additional clarification or public notice.
The proposed changes would impact reimbursement rates, telehealth services, and much more.
The meeting covered 2024 healthcare costs and utilization, along with incoming regulatory changes.
The meeting covered fee schedule policies impacting physician-dispensed medication, electronic delivery for EOBs, and more.
The next meeting in October will deliver an expanded formulary list, with a review of the top five to ten exempt drugs based on utilization.
The July 16th meeting will review upcoming MTUS changes, which go into effect August 6th.
The meeting focused on long-term disability claims, going into IMEs and PTSD claims.
Fee schedule clarity and defined reimbursement caps were discussed as ways to reduce ambiguity and prevent payment disputes.
The meeting will take place on June 12th, aiming to explore current trends, challenges, and proposed solutions related to these drugs.
Topics addressed included changes to the fee schedule, utilization review, spinal therapy guidelines, and more.
The exemption reduces unnecessary burden and grows recognition that workers’ comp PBMs operate differently from traditional PBMs.
After previous drafts of new rules were withdrawn last year, a revised set of rules have been introduced, based on stakeholder feedback.
The pilot test will run from April 24 to May 8, 2025, allowing stakeholders to provide feedback to the DWC.
A June 16th virtual hearing will discuss proposed rules, and those interested in speaking must register by May 2nd.
The hybrid meeting will cover the pharmacy fee schedule, biosimilars, cannabis coverage, and payments for topical drugs.
